Home LiteratureArticle Details
PMID: 14523475 Published · ppublish English Letter Research Support, Non-U.S. Gov't

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.

Leukemia ·Vol. 17 ·No. 11 ·2003-11-00 ·Pages 2249-50

Robinson HM, Broadfield ZJ, Cheung KL, Harewood L, Harris RL, Jalali GR, Martineau M, Moorman AV, Taylor KE, Richards S, Mitchell C, Harrison CJ

Abstract

暂无摘要

MeSH Terms
Child Child, Preschool Core Binding Factor Alpha 2 Subunit DNA-Binding Proteins/genetics Disease-Free Survival Gene Amplification Humans Immunophenotyping Neoplasm Proteins/genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics,mortality Prognosis Proto-Oncogene Proteins Time Factors Transcription Factors/genetics Treatment Outcome
Chemicals
Core Binding Factor Alpha 2 Subunit DNA-Binding Proteins Neoplasm Proteins Proto-Oncogene Proteins RUNX1 protein, human Transcription Factors
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Robinson H M
Broadfield Z J
Cheung K L
Harewood L
Harris R L
Jalali G R
Martineau M
Moorman A V
Taylor K E
Richards S
Mitchell C
Harrison C J
Article Info
Journal
Leukemia
Abbr.
Leukemia
ISSN
0887-6924
Published
2003-11-00
Pages
2249-50
Language
English
Region
England
NLM ID
8704895
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com